Amarin Corporation plc [NASDAQ: AMRN] closed the trading session at $7.56 on 01/25/21. The day’s price range saw the stock hit a low of $6.96, while the highest price level was $7.64. The company report on January 26, 2021 that Amarin Expands Cardiovascular Risk Reduction Patent Infringement Lawsuit to Include Health Care Insurance Provider.
Amarin Corporation plc (NASDAQ:AMRN), announced an expansion of the scope of its VASCEPA® (icosapent ethyl) cardiovascular (CV) risk reduction patent infringement lawsuit against Hikma Pharmaceuticals PLC to include a health care insurance provider in the United States, Health Net, LLC. The lawsuit was filed in the United States District Court in Delaware. A copy of the amended complaint is available through the FAQ section of the Amarin investor relations website.
Multiple healthcare insurance providers and managed care enterprises have respected Amarin’s patent rights. As detailed in the complaint, Health Net is not among them. Through insurance coverage and economic incentives Amarin alleges that Health Net has actively induced pharmacies to dispense, and patients to use, Hikma generic icosapent ethyl capsules in infringement of U.S. Patent Nos. 9,700,537 (Composition for preventing the occurrence of cardiovascular event in multiple risk patient), 8,642,077 (Stable pharmaceutical composition and methods of using same), and 10,568,861 (Methods of reducing the risk of a cardiovascular event in a subject at risk for cardiovascular disease).
The stocks have a year to date performance of 54.60 percent and weekly performance of 24.55 percent. The stock has been moved at 15.95 percent over the last six months. The stock has performed 52.73 percent around the most recent 30 days and changed 50.60 percent over the most recent 3-months.
If compared to the average trading volume of 7.48M shares, AMRN reached to a volume of 13819299 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Amarin Corporation plc [AMRN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for AMRN shares is $10.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on AMRN stock is a recommendation set at 2.20. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
JP Morgan have made an estimate for Amarin Corporation plc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on September 29, 2020. While these analysts kept the previous recommendation, Piper Sandler raised their target price to Overweight. The new note on the price target was released on August 26, 2020, representing the official price target for Amarin Corporation plc stock. Previously, the target price had yet another raise to $15, while Northland Capital analysts kept a Outperform rating on AMRN stock.
The Average True Range (ATR) for Amarin Corporation plc is set at 0.40, with the Price to Sales ratio for AMRN stock in the period of the last 12 months amounting to 4.80. The Price to Book ratio for the last quarter was 4.91, with the Price to Cash per share for the same quarter was set at 1.50. Price to Free Cash Flow for AMRN in the course of the last twelve months was 404.55 with Quick ratio for the last quarter at 2.30.
AMRN stock trade performance evaluation
Amarin Corporation plc [AMRN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 24.55. With this latest performance, AMRN shares gained by 52.73% in over the last four-week period, additionally plugging by 15.95% over the last 6 months – not to mention a drop of -62.61% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AMRN stock in for the last two-week period is set at 80.49, with the RSI for the last a single of trading hit 86.25, and the three-weeks RSI is set at 75.51 for Amarin Corporation plc [AMRN]. The present Moving Average for the last 50 days of trading for this stock 5.15, while it was recorded at 6.58 for the last single week of trading, and 5.92 for the last 200 days.
Amarin Corporation plc [AMRN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Amarin Corporation plc [AMRN] shares currently have an operating margin of -5.65 and a Gross Margin at +77.46. Amarin Corporation plc’s Net Margin is presently recorded at -5.27.
Return on Total Capital for AMRN is now -5.41, given the latest momentum, and Return on Invested Capital for the company is -5.57. Return on Equity for this stock declined to -5.98, with Return on Assets sitting at -3.59. When it comes to the capital structure of this company, Amarin Corporation plc [AMRN] has a Total Debt to Total Equity ratio set at 9.85. Additionally, AMRN Total Debt to Total Capital is recorded at 8.97, with Total Debt to Total Assets ending up at 6.79. Long-Term Debt to Equity for the company is recorded at 1.61, with the Long-Term Debt to Total Capital now at 1.41.
Reflecting on the efficiency of the workforce at the company, Amarin Corporation plc [AMRN] managed to generate an average of -$23,563 per employee. Receivables Turnover for the company is 4.72 with a Total Asset Turnover recorded at a value of 0.68.Amarin Corporation plc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.30 and a Current Ratio set at 2.70.
Earnings per share (EPS) analysis for Amarin Corporation plc [AMRN] stock
With the latest financial reports released by the company, Amarin Corporation plc posted 0.02/share EPS, while the average EPS was predicted by analysts to be reported at -0.02/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 200.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for AMRN. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Amarin Corporation plc go to 38.90%.
Amarin Corporation plc [AMRN]: Insider Ownership positions
There are presently around $1,109 million, or 39.30% of AMRN stock, in the hands of institutional investors. The top three institutional holders of AMRN stocks are: BAKER BROS. ADVISORS LP with ownership of 32,018,867, which is approximately -7.183% of the company’s market cap and around 1.00% of the total institutional ownership; EVERSEPT PARTNERS, LP, holding 10,653,459 shares of the stock with an approximate value of $80.54 million in AMRN stocks shares; and BOXER CAPITAL, LLC, currently with $52.92 million in AMRN stock with ownership of nearly 0% of the company’s market capitalization.
Positions in Amarin Corporation plc stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 122 institutional holders increased their position in Amarin Corporation plc [NASDAQ:AMRN] by around 35,861,546 shares. Additionally, 127 investors decreased positions by around 51,631,908 shares, while 67 investors held positions by with 59,206,171 shares. The mentioned changes placed institutional holdings at 146,699,625 shares, according to the latest SEC report filing. AMRN stock had 41 new institutional investments in for a total of 16,635,506 shares, while 57 institutional investors sold positions of 8,701,574 shares during the same period.